Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder

SQUASSINA, ALESSIO;MANCHIA, MIRKO;DEL ZOMPO, MARIA
2010-01-01

Abstract

Bipolar disorder (BD) is a chronic and often severe psychiatric illness characterized by manic and depressive episodes. Among the most effective treatments, mood stabilizers represent the keystone in acute mania, depression, and maintenance treatment of BD. However, treatment response is a highly heterogeneous trait, thus emphasizing the need for a structured informational framework of phenotypic and genetic predictors. In this paper, we present the current state of pharmacogenomic research on long-term treatment in BD, specifically focusing on mood stabilizers. While the results provided so far support the key role of genetic factors in modulating the response phenotype, strong evidence for genetic predictors is still lacking. In order to facilitate implementation of pharmacogenomics into clinical settings (i.e., the creation of personalized therapy), further research efforts are needed.
2010
Inglese
2010
1
19
19
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958627/pdf/HGP2010-159761.pdf
Esperti anonimi
internazionale
scientifica
Citazioni: 4
no
Squassina, Alessio; Manchia, Mirko; DEL ZOMPO, Maria
1.1 Articolo in rivista
info:eu-repo/semantics/article
1 Contributo su Rivista::1.1 Articolo in rivista
262
3
open
Files in This Item:
File Size Format  
Squassina_2010_HGP.pdf

open access

Type: versione editoriale
Size 668.87 kB
Format Unknown
668.87 kB Unknown View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Questionnaire and social

Share on:
Impostazioni cookie